% IMPORTANT: The following is UTF-8 encoded.  This means that in the presence
% of non-ASCII characters, it will not work with BibTeX 0.99 or older.
% Instead, you should use an up-to-date BibTeX implementation like “bibtex8” or
% “biber”.

@ARTICLE{Wahl:904383,
      author       = {Wahl, Richard L. and Chareonthaitawee, Panithaya and
                      Clarke, Bonnie and Drzezga, Alexander and Lindenberg, Liza
                      and Rahmim, Arman and Thackeray, James and Ulaner, Gary A.
                      and Weber, Wolfgang and Zukotynski, Katherine and
                      Sunderland, John},
      title        = {{M}ars {S}hot for {N}uclear {M}edicine, {M}olecular
                      {I}maging, and {M}olecularly {T}argeted
                      {R}adiopharmaceutical {T}herapy},
      journal      = {Journal of nuclear medicine},
      volume       = {62},
      number       = {1},
      issn         = {0022-3123},
      address      = {New York, NY},
      publisher    = {Soc.},
      reportid     = {FZJ-2021-05953},
      pages        = {6 - 14},
      year         = {2021},
      abstract     = {AbstractThe Society of Nuclear Medicine and Molecular
                      Imaging created the Value Initiative in 2017 as a major
                      component of its strategic plan to further demonstrate the
                      value of molecular imaging and molecularly targeted
                      radiopharmaceutical therapy to patients, physicians, payers,
                      and funding agencies. The research and discovery domain, 1
                      of 5 under the Value Initiative, has a goal of advancing the
                      research and development of diagnostic and therapeutic
                      nuclear medicine. Research and discovery efforts and
                      achievements are essential to ensure a bright future for NM
                      and to translate science to practice. Given the remarkable
                      progress in the field, leaders from the research and
                      discovery domain and society councils identified 5 broad
                      areas of opportunity with potential for substantive growth
                      and clinical impact. This article discusses these 5 growth
                      areas, identifying specific areas of particularly high
                      importance for future study and development. As there was an
                      understanding that goals should be both visionary yet
                      achievable, this effort was called the Mars shot for nuclear
                      medicine.Keywords: artificial intelligence; molecular
                      imaging; neuroimaging; radiopharmaceutical therapy;
                      theranostics.},
      cin          = {INM-2},
      ddc          = {610},
      cid          = {I:(DE-Juel1)INM-2-20090406},
      pnm          = {5253 - Neuroimaging (POF4-525)},
      pid          = {G:(DE-HGF)POF4-5253},
      typ          = {PUB:(DE-HGF)16},
      pubmed       = {33334911},
      UT           = {WOS:000621928600004},
      doi          = {10.2967/jnumed.120.253450},
      url          = {https://juser.fz-juelich.de/record/904383},
}